The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

70 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology